Brief: hVIVO To Conduct Phase Iii Human Challenge Whooping Cough Vaccine Trial For ILiAD Biotechnologies
22/04/2026 07:54
April 22 (Reuters) - hVIVO PLC HVO.L: HVIVO PLC - HCT CONTRACT SIGNED WITH ILIAD BIOTECHNOLOGIES HVIVO - TO CONDUCT PHASE III HUMAN CHALLENGE WHOOPING COUGH VACCINE TRIAL FOR ILIAD BIOTECHNOLOGIES HVIVO - MAJORITY OF REVENUE FROM TRIAL EXPECTED TO BE RECOGNISED IN 2026 AND 2027 Source text: ID:nRSV3809Ba Further company coverage: HVO.L (((( Reuters.Briefs@thomsonreuters.com ;));))